Palo Alto, CANCT06578429Now EnrollingIRB Ready

Methamphetamine Use Disorder Clinical Trial in Palo Alto, CA

Access cutting-edge methamphetamine use disorder treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.

Sponsored by Stanford University

Quick Self-Assessment

See if you qualify for this Palo Alto location

Preparing your pre-screening questions…

Expert Care in Palo Alto

Access methamphetamine use disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related methamphetamine use disorder treatment provided free

Apply for This Palo Alto Location

Check if you qualify for this methamphetamine use disorder clinical trial in Palo Alto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Palo Alto

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Palo Alto site if eligible
  4. 4Begin participation

About This Methamphetamine Use Disorder Study in Palo Alto

This study aims to evaluate the efficacy of deep transcranial magnetic stimulation (dTMS) as a treatment for Veterans with a methamphetamine use disorder (MUD).

Sponsor: Stanford University

Who Can Participate

Inclusion Criteria

Must be within the age range of 25-75.
Participants must meet Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for moderate to severe MUD (≥4 diagnostic symptoms).
Participants must be able to obtain a Motor Threshold (MT), which will be determined during the screening process.
Participants must have an adequately stable condition and environment to enable attendance at scheduled clinic visits.
Participants must be able to read, verbalize, understand, and voluntarily sign the Informed Consent Form prior to participation in study procedures in English.
If participants are on a medication regimen for comorbid symptoms, that regimen will be stable for the duration of the study and patient will be willing to remain on this regimen during the treatment phase.
Participants must be fluent in English

Exclusion Criteria

Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI) contraindications: such as a cardiac pacemaker, cochlear implant, or an implanted device (deep brain stimulation, ferromagnetic metal in the head and body, claustrophobia, pregnant or breastfeeding or other ferromagnetic device/object in the head and body within 30 cm of the treatment coil.
General medical condition, disease, or neurological disorder that interferes with the assessments or participation.
Unable to safely withdraw, at least two weeks prior to treatment, from medications that increase seizure risk.
Current substance abuse as determined by positive toxicology screen
Have a mass lesion, cerebral infarct, or other active CNS disease, including a seizure disorder.
A recent suicide attempt (defined as within the last 30 days) or presence of current suicidal plan or intent. Patients at risk for suicide will be required to establish a written safety plan involving their primary therapist before entering the study.
Severe impediment to vision, hearing and/or hand movement, as this is likely to interfere with the ability to follow study protocols.
Greater than mild traumatic brain injury (defined as greater than 10 minutes loss of consciousness).
Taking benzodiazepines or neuroleptic medications, or any medication known to alter seizure threshold.
Acute or unstable chronic illness.
Current or lifetime history of bipolar disorder or psychosis.
Participation in another concurrent intervention-based clinical trial.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Palo Alto?

Yes, this clinical trial (NCT06578429) has an active research site in Palo Alto, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Methamphetamine Use Disorder Treatment Options in Palo Alto, CA

If you're searching for methamphetamine use disorder treatment options in Palo Alto, CA, this clinical trial (NCT06578429) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced methamphetamine use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all methamphetamine use disorder clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Palo Alto, CA

See all heart attack clinical trials recruiting in Palo Alto — not just this study.

Browse Heart Attack Trials in Palo Alto →

Browse More Trials by Condition

Heart Attack TrialsEssential Tremor TrialsPulmonary Hypertension TrialsMyocardial Infarction TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Palo Alto?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Palo Alto, CA